Barings Global Short Duration High Yield Fund to Host

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Barings Global Short Duration High Yield Fund to Host Quarterly Investor Call

CHARLOTTE, N.C., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Barings Global Short Duration High Yield Fund (the “Fund”) (NYSE: BGH ) will host its quarterly investor conference call to discuss the Fund’s investment positioning, recent performance and market outlook.

Date: November 9, 2016 Time: 12:00 pm ET Dial-in Number: 1.855.219.1505 Passcode: 14342254

A replay of the call will be available until January 09, 2017. Replay number: 1.855.859.2056 Passcode: 14342254

The Fund is a non-diversified, closed-end management investment company that is managed by Barings LLC. The Fund invests primarily in short-duration, global high yield bonds with the objective of seeking as high a level of current income as Barings determines is consistent with capital preservation, with a secondary objective of capital appreciation.  The Fund expects to maintain a weighted average portfolio duration, including the effects of leverage, of three years or less. Please refer to http://www.barings.com/funds/closed-end-funds...yield-fund for further information about the Fund.

Cautionary Notice: Certain statements contained in this press release may be "forward looking" statements.  Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date in which they are made and which reflect management’s current estimates, projections, expectations or beliefs, and which are subject to risks and uncertainties that may cause actual results to differ materially.  These statements are subject to change at any time based upon economic, market or other conditions and may not be relied upon as investment advice or an indication of the fund's trading intent.  References to specific securities are not recommendations of such securities, and may not be representative of the fund's current or future investments.  We undertake no obligation to publicly update forward looking statements, whether as a result of new information, future events, or otherwise. 

Because the Fund is newly organized, its shares have a limited history of public trading. Investors should read the Fund’s prospectus and consider carefully the risks, investment objectives, charges and expenses associated with an investment in the Fund’s common shares. For a copy of the prospectus, please contact your securities representative.

An investment in the Fund is not appropriate for all investors and is not intended to be a complete investment program. The Fund is designed as a long-term investment and not as a trading vehicle. Investing in the Fund involves risks, including the risk that you may receive little or no return on your investment or that you may lose part or even all of your investment. The Fund invests in high yield bonds, commonly referred to as “junk bonds,” including distressed securities, which are subject to greater credit risk (the risk that an issuer won’t make timely payments of principal and interest) and market risk (the risk that the value of the Fund’s investments may fall, sometimes rapidly or unpredictably, as a result of increasing interest rates or otherwise); loans and derivative securities, which may carry market, credit and liquidity risk (the risk that the Fund’s investments may be difficult to sell at an advantageous time or price); foreign securities, which are subject to additional risks including political and economic risks. The Fund employs leveraging techniques, which may magnify losses, increase portfolio expenses, cause the Fund’s NAV and distributions to be more volatile, and are subject to non-diversification risk, which may subject the Fund to greater losses in response to a single economic, political or regulatory development than funds that are more diversified. The Fund may trade at a discount to its net asset value and is subject to anti-takeover provisions that may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of Fund shareholders. Portfolios investing in derivatives could lose more than the principal amount invested in those instruments. Before investing you should consider carefully the Fund’s investment objectives, risks, charges and expenses. For more complete information about the Fund, please see the prospectus.

About Barings Barings is a $284 billion* global asset management firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. A member of the MassMutual Financial Group, Barings maintains a strong global presence with over 600 investment professionals and offices in 17 countries. Babson Capital Management, Cornerstone Real Estate Advisers and Wood Creek Capital Management are now operating as a unified company under the Barings name. Learn more, at www.barings.com .

*As of September 30, 2016.

16/2479

Contact: Brian Whelan, Barings, (980) 417-7700,

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 353

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 395

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 8

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading

Top 5 Most Recently Viewed Articles

DENTSPLY SIRONA Inc. Faces Class Action for Alleged Fraud

Updated Category News Views 255

DENTSPLY SIRONA Inc. Faces Legal Challenges The law firm Kessler Topaz Meltzer & Check, LLP has informed investors about a securities class action lawsuit filed against DENTSPLY SIRONA Inc. (NASDAQ: XRAY). This lawsuit could have significant implications for investors who acquired DENTSPLY common stock between certain periods. Important Details for Investors Investors who...

Continue Reading
Revolutionizing Comfort in Urine Collection Systems

Updated Category News Views 166

Innovative External Urine Collection System An inventive individual from Stanwood has developed a groundbreaking external urine collection system aimed at improving comfort and health outcomes. The new system, known as the PART TIME CARETAKER, is designed to replace traditional indwelling urinary catheters. The inventor emphasizes the importance of comfort and reducing...

Continue Reading
Exploring Investors' Recent Movements in Apple Options

Updated Category News Views 132

Understanding Recent Investment Trends in Apple Options Recent activity in the options market shows that wealthy investors are betting on a positive outlook for Apple (NASDAQ:AAPL). This is notable for retail traders who closely monitor market dynamics. Insights from Option Trading Data Publicly available options trading history reveals an intriguing landscape of...

Continue Reading
Fat of the Land Expands to Irvine, Boosts Dining Scene

Updated Category News Views 30

Irvine Welcomes New Dining Destination And there it is, a fresh dining oasis gearing up to turn some heads out in Irvine. The Centerview is about to get even spicier with Fat of the Land, a celebrated tapas joint from Robert Paetz, making its way from Santa Ana to redefine what it means to dine in style. The Appeal of a ‘Third Space’ We’re not just talking about...

Continue Reading
Understanding Kaixin Holdings' Share Consolidation Strategy

Updated Category News Views 122

Key Announcement from Kaixin Holdings Kaixin Holdings, a prominent entity in the new energy vehicle sector, recently shared an important update regarding its financial structure. The company announced a share consolidation, which will take place at a ratio of 1-for-60. This consolidation is aimed at refining its capital structure and enhancing shareholder value. Details...

Continue Reading